Lairus Pharma persistently capitalizes in research and development (R&D) to develop new products and technologies aimed at achieving the company's vision. In addition to complex chemistry challenges, Lairus's R&D is specifically aware of developing a novel, cost-effective, environmentally friendly, non-infringing process for advanced intermediates and key API raw materials. A well-established research and development center includes the Kilo Lab, which has vessels ranging from 5.0 liters to 300 liters of glass line reactors to support commercialization batches in production to address scale-up issues. We specialize and have expertise in the development of chiral molecules through a resolution process with precise measure. The goal of R&D research is to reduce inventory, manufacturing time, and process effluents. The research and development division scientist and technologist can efficiently produce new molecule processes. Scientific research strategy is used to develop a good process for producing high-quality products. Our chemistry study simplifies the process of preparing any complex molecules by our expert scientist. In addition to being a contract research organization, Lairus develops processes for pharmaceutical intermediates. The R&D department is supported by a well-equipped lab with high-quality HPLC, GC, UV, and KF instruments, among others. We are able to generate online documentation for several stages of process development, including scaling, safety and technical reports that help to have a safe and robust process in production.